Literature DB >> 25430867

Grants4Targets: an open innovation initiative to foster drug discovery collaborations.

Heidrun Dorsch1, Alina Elisabeth Jurock1, Stefanie Schoepe1, Monika Lessl2, Khusru Asadullah1.   

Abstract

Mesh：

Year:  2014        PMID： 25430867     DOI： 10.1038/nrd3078-c2

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  9 in total

1.  Industry-academia collaborations for biomarkers.

Authors:  Khusru Asadullah; Andreas Busch; Matthias Gottwald; Petra Reinke; Lilla Landeck
Journal:  Nat Rev Drug Discov       Date:  2015-10-30       Impact factor: 84.694

2.  Preclinical research strategies for newly approved drugs as reflected in early publication patterns.

Authors:  Ursula Köster; Ingo Nolte; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-26       Impact factor: 3.000

3.  Expectations and satisfaction of academic investigators in nonclinical collaboration with the pharmaceutical industry.

Authors:  Marjan Amiri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-28       Impact factor: 3.000

Review 4.  Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB).

Authors:  Sean Ekins; Anna Coulon Spektor; Alex M Clark; Krishna Dole; Barry A Bunin
Journal:  Drug Discov Today       Date:  2016-11-22       Impact factor: 7.851

5.  Establishing a reliable framework for harnessing the creative power of the scientific crowd.

Authors:  Adrian J Carter; Amy Donner; Wen Hwa Lee; Chas Bountra
Journal:  PLoS Biol       Date:  2017-02-15       Impact factor: 8.029

Review 6.  Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?

Authors:  Alexander Schuhmacher; Oliver Gassmann; Nigel McCracken; Markus Hinder
Journal:  J Transl Med       Date:  2018-05-08       Impact factor: 5.531

Review 7.  Changing Trends in Computational Drug Repositioning.

Authors:  Jaswanth K Yella; Suryanarayana Yaddanapudi; Yunguan Wang; Anil G Jegga
Journal:  Pharmaceuticals (Basel)       Date:  2018-06-05

Review 8.  Changing R&D models in research-based pharmaceutical companies.

Authors:  Alexander Schuhmacher; Oliver Gassmann; Markus Hinder
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531

Review 9.  Crowdsourcing and open innovation in drug discovery: recent contributions and future directions.

Authors:  David C Thompson; Jörg Bentzien
Journal:  Drug Discov Today       Date:  2020-10-02       Impact factor: 7.851
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.